• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.08% Nasdaq Down0.37%

    BioMarin Pharmaceutical Inc. (BMRN)

    96.97 Down 0.28(0.29%) 9:39AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.8
    Mean Recommendation (last week):1.8

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:107.06
    Median Target:105.50
    High Target:125.00
    Low Target:90.00
    No. of Brokers:16

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 10, 2014BarclaysDowngradeOverweightEqual Weight
    Sep 18, 2013StifelDowngradeBuyHold
    Jan 22, 2013Stifel NicolausUpgradeHoldBuy
    Nov 6, 2012Brean CapitalDowngradeBuyHold
    Aug 27, 2012Deutsche BankDowngradeBuyHold
    Aug 24, 2012BarclaysInitiated Overweight
    Apr 12, 2012UBSInitiated Buy
    Mar 26, 2012Canaccord GenuityInitiated Buy
    Sep 28, 2011Deutsche BankUpgradeHoldBuy
    Sep 16, 2011RBC Capital MktsInitiated Outperform

    More Upgrades & Downgrades for BMRN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy6566

    Data provided by Thomson/First Call

    Currency in USD.